A remarkable story of science and survival, fueled by a frontier mentality that defines UT Southwestern Medical Center, leads to the development of a new drug that gives fresh hope to patients with low-grade gliomas.
Two studies underway at UT Southwestern are building upon existing nanoparticle technology to deliver brain cancer medications directly to the brain. UT Southwestern discusses how the ReSPECT clinical trials may give hope to patients living with glioblastoma and leptomeningeal disease.
UT Southwestern's neurosurgery team recently performed the first two fluorescence-guided brain tumor removals in the Dallas-Fort Worth region, using an advanced technology that makes the cancer cells glow so it is easier to see and remove them. UT Southwestern discusses the effect of this advanced treatment for glioblastoma, the most common and aggressive form of brain tumor.
